S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

AVTX Avalo Therapeutics Inc

7.73

0.07 (0.91%)

Last Updated: 04:25:55

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Avalo Therapeutics (NASDAQ:AVTX)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Avalo Therapeutics Charts.

Avalo Therapeutics (NASDAQ:AVTX)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Avalo Therapeutics Charts.

Avalo Therapeutics Inc News

Avalo Therapeutics to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
Wednesday 5 February 2025 (1 week ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Friday 31 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 31 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 31 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 31 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 13 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Saturday 4 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 2 January 2025 (1 month ago) • Edgar (US Regulatory)

Avalo Therapeutics Appoints Jennifer Riley as Chief Strategy Officer
Thursday 2 January 2025 (1 month ago) • GlobeNewswire Inc.

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Wednesday 1 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 5 December 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (3 months ago) • Edgar (US Regulatory)

More Avalo Therapeutics Inc News Articles

Picton Mahoney Fortified...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions